DIA Conference 2022 | Booth E04
March 23, 2022
Veristat and SFL, a Veristat company, attend DIA Europe 2022
Gene Therapy for Rare Disorders 2022 | Booth #22
February 3, 2022
Meet Veristat at the Gene Therapy for Rare Disorders Conference 2022 in Boston, MA - March 7-10, 2022 at Booth 22
ACDM Annual Conference 2022 | Booth #17
January 20, 2022
Meet Veristat at the ACDM Annual Conference 2022 taking place on the 13th -15th March 2022, Booth #17
The Potential for New Efficiencies to Allow for Scalability in Cell and Gene Therapy Clinical Development
2021 TOPRA Awards Event
July 27, 2021
Veristat To Sponsor the TOPRA Awards 2021
London - UK 18th November 2021
Orphan Drug Congress Europe | Booth #54
July 9, 2021
Meet Veristat at the Orphan Drug Congress 2021 taking place on 15-18 November 2021, Booth #54
Veristat experts recently led an Xtalks webinar on lessons learned for planning decentralized clinical trials.
Webinar | Roadmap to Market for Cell and Gene Therapies
October 12, 2020
View the On-Demand Webinar
Nothing is standard about the study design, study conduct or the regulatory process in cell and gene therapy trials. Every cell and gene therapy is different due to the specific characteristics of each product, with a complicated regulatory approval process and unique therapeutic challenges.